Búsqueda | Biblioteca Virtual en Salud

1.

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection.

Yokosuka, Osamu; Takaguchi, Koichi; Fujioka, Shinichi; Shindo, Michiko; Chayama, Kazuaki; Kobashi, Haruhiko; Hayashi, Norio; Sato, Chifumi; Kiyosawa, Kendo; Tanikawa, Kyuichi; Ishikawa, Hiroki; Masaki, Nobuyuki; Seriu, Taku; Omata, Masao.

J Hepatol ; 52(6): 791-9, 2010 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-20409606

2.

A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.

Omata, Masao; Yoshida, Haruhiko; Toyota, Joji; Tomita, Eiichi; Nishiguchi, Shuhei; Hayashi, Norio; Iino, Shiro; Makino, Isao; Okita, Kiwamu; Toda, Gotaro; Tanikawa, Kyuichi; Kumada, Hiromitsu.

Gut ; 56(12): 1747-53, 2007 Dec.

Artículo en Inglés | MEDLINE | ID: mdl-17573387

3.

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients.

Matsumoto, Akihiro; Tanaka, Eiji; Rokuhara, Akinori; Kiyosawa, Kendo; Kumada, Hiromitsu; Omata, Masao; Okita, Kiwamu; Hayashi, Norio; Okanoue, Takeshi; Iino, Shiro; Tanikawa, Kyuichi.

Hepatol Res ; 32(3): 173-84, 2005 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16024289

4.

Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels.

Iino, Shiro; Tomita, Eiichi; Kumada, Hiromitsu; Suzuki, Hiroshi; Toyota, Johji; Kiyosawa, Kendo; Tanikawa, Kyuichi; Sata, Michio; Hayashi, Norio; Kakumu, Shinichi; Matsushima, Takashi; Mizokami, Masashi.

Hepatol Res ; 31(2): 88-94, 2005 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-15777649

5.

Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy.

Iino, Shiro; Tomita, Eiichi; Kumada, Hiromitsu; Suzuki, Hiroshi; Toyota, Joji; Kiyosawa, Kendo; Tanikawa, Kyuichi; Sata, Michio; Hayashi, Norio; Kakumu, Shinichi; Matsushima, Takashi; Ohno, Tomoyoshi.

Hepatol Res ; 30(2): 63-70, 2004 Oct.

Artículo en Inglés | MEDLINE | ID: mdl-15519269

6.

Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene.

Kumashiro, Ryukichi; Kubota, Takahiro; Koga, Yuriko; Tanaka, Masatoshi; Inada, Chizuko; Kusaba, Nobuhide; Yoshida, Hiroshi; Hisamochi, Akiko; Ide, Tatsuya; Tomita, Yuko; Masumoto, Naoko; Tanikawa, Kyuichi; Iga, Tatsuji; Sata, Michio.

Hepatol Res ; 26(4): 337-342, 2003 Aug.

Artículo en Inglés | MEDLINE | ID: mdl-12963435

7.

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

Kumashiro, Ryukichi; Ide, Tatsuya; Sasaki, Masaru; Murashima, Shiro; Suzuki, Hiroshi; Hino, Teruko; Morita, Yasuyo; Miyajima, Ichiro; Ogata, Kei; Tanaka, Eisuke; Yoshida, Hiroshi; Tanikawa, Kyuichi; Sata, Michio.

Hepatol Res ; 22(1): 20-26, 2002 Jan.

Artículo en Inglés | MEDLINE | ID: mdl-11804830

8.

Pathogenesis and treatment of hepatitis C virus-related liver diseases.

Tanikawa, Kyuichi.

Hepatobiliary Pancreat Dis Int ; 3(1): 17-20, 2004 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-14969831

9.

Markedly prolonged jaundice from simultaneous infection with hepatitis E virus and leptospira.

Suzuki, Asuka; Kumashiro, Ryukichi; Shirachi, Miki; Kuroki, Mina; Suzuki, Hiroshi; Tanikawa, Kyuichi; Sata, Michio.

Kurume Med J ; 50(3-4): 155-9, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-14768480

10.

An overview of novel and therapeutic approaches to hepatocellular carcinoma--Japanese experiences.

Tanikawa, Kyuichi.

Gan To Kagaku Ryoho ; 29 Suppl 1: 106-9, 2002 Feb.

Artículo en Inglés | MEDLINE | ID: mdl-11890095

11.

[Introduction to hepatitis A].

Tanikawa, Kyuichi.

Nihon Rinsho ; 62 Suppl 8: 453-7, 2004 Aug.

Artículo en Japonés | MEDLINE | ID: mdl-15453364

12.

[Hepatic biopsy].

Tanikawa, Kyuichi.

Nihon Naika Gakkai Zasshi ; 91(2): 540-3, 2002 Feb 10.

Artículo en Japonés | MEDLINE | ID: mdl-11917467

13.

[Type III procollagen-N-peptide (P III P)].

Ueno, Takato; Tanikawa, Kyuichi.

Nihon Rinsho ; 62 Suppl 11: 314-6, 2004 Nov.

Artículo en Japonés | MEDLINE | ID: mdl-15628405

14.

Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B.

Kobashi, Haruhiko; Fujioka, Shin-Ichi; Kawaguchi, Mitsuhiko; Kumada, Hiromitsu; Yokosuka, Osamu; Hayashi, Norio; Suzuki, Kazuyuki; Okanoue, Takeshi; Sata, Michio; Tsubouchi, Hirohito; Sato, Chifumi; Kiyosawa, Kendo; Tanikawa, Kyuichi; Seriu, Taku; Ishikawa, Hiroki; Takaki, Akinobu; Iwasaki, Yoshiaki; Osawa, Toshiya; Takaki, Toshiyuki; Sakaguchi, Kosaku; Shiratori, Yasushi; Yamamoto, Kazuhide; Tenney, Daniel J; Omata, Masao.

Hepatol Int ; 3(2): 403-10, 2009 Jun.

Artículo en Inglés | MEDLINE | ID: mdl-19669367

15.

Studies on oxidative stress in liver diseases: important future trends in liver research.

Tanikawa, Kyuichi; Torimura, Takuji.

Med Mol Morphol ; 39(1): 22-7, 2006 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-16575511

16.

A message to Japan.

Tanikawa, Kyuichi.

Oncology ; 62 Suppl 1: 101-2, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-11868777

17.

beta1-Integrin mediates cell adhesion, haptotaxis, and chemokinesis of hepatoma cells.

Torimura, T.; Ueno, Takato; Kin, Motoaki; Sakisaka, Shotaro; Tanikawa, Kyuichi; Sata, Michio.

Med Electron Microsc ; 32(1): 2-10, 1999 May.

Artículo en Inglés | MEDLINE | ID: mdl-11810419

18.

Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases.

Kawaguchi, Takumi; Harada, Masaru; Arimatsu, Hidetoshi; Nagata, Shuichiro; Koga, Yuriko; Kuwahara, Reiichiro; Hisamochi, Akiko; Hino, Teruko; Taniguchi, Eitaro; Kumemura, Hiroto; Hanada, Shinichiro; Maeyama, Michiko; Koga, Hironori; Tomiyasu, Nobuo; Toyomasu, Hiroyuki; Kawaguchi, Motonari; Kage, Masayoshi; Kumashiro, Ryukichi; Tanikawa, Kyuichi; Sata, Michio.

J Gastroenterol Hepatol ; 19(3): 349-50, 2004 Mar.

Artículo en Inglés | MEDLINE | ID: mdl-14748890

Biblioteca Virtual en Salud

Hipertensión

Su selección (0)

Formato de exportación:

Exportar:

Long-term use of entecavir in nucleoside-naïve Japanese patients with chronic hepatitis B infection.

A large-scale, multicentre, double-blind trial of ursodeoxycholic acid in patients with chronic hepatitis C.

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients.

Impact of daily high-dose IFNalpha-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels.

Prediction of treatment outcome with daily high-dose IFN alpha-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels: relationship of baseline viral levels and viral dynamics during and after therapy.

Association of troglitazone-induced liver injury with mutation of the cytochrome P450 2C19 gene.

Interferon-gamma brings additive anti-viral environment when combined with interferon-alpha in patients with chronic hepatitis C.

Pathogenesis and treatment of hepatitis C virus-related liver diseases.

Markedly prolonged jaundice from simultaneous infection with hepatitis E virus and leptospira.

An overview of novel and therapeutic approaches to hepatocellular carcinoma--Japanese experiences.

[Introduction to hepatitis A].

[Hepatic biopsy].

[Type III procollagen-N-peptide (P III P)].

Two cases of development of entecavir resistance during entecavir treatment for nucleoside-naive chronic hepatitis B.

Studies on oxidative stress in liver diseases: important future trends in liver research.

A message to Japan.

beta1-Integrin mediates cell adhesion, haptotaxis, and chemokinesis of hepatoma cells.

Severe hepatotoxicity associated with a N-nitrosofenfluramine-containing weight-loss supplement: report of three cases.